Cambridge biotechs among big winners at ASH blood disease conference

A handful of local biotechs were among the major headliners this weekend at the American Society of Hematology ’s annual blood disease conference in Atlanta. During the ASH conference, which runs through Tuesday, companies from across the country gather to unveil new data from trials of their drugs for blood cancer and other diseases, with investors keeping close tabs on the presentations. Here’s a look at four Cambridge-based biotechs that are making noise so far: bluebird bio (Nasdaq: BLUE):…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news